Multi-Tasking Clot-Busting Enzymes
10/08/2012
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma...
Breast Cancer Symptom Management May Be Improved By Memory, Thought-Process Training
10/07/2012
A new Indiana University study is the first of its kind to show it may be possible to improve memory and thought process speed among breast cancer survivors. Diane M. Von Ah, Ph.D., R.N...
Transplant, Lymphoma Patients At Greater Risk Of Melanoma
10/06/2012
Melanoma is on the rise nationally, and transplant recipients and lymphoma patients are far likelier than the average person to get that form of skin cancer and to die from it, a Mayo Clinic review has found. That is because their immune systems tend to be significantly depressed, making early detection of melanoma even more important, says co-author Jerry Brewer, M.D., a Mayo dermatologist...
Boehringer Ingelheim has announced new patient-reported health-related outcomes for its investigational oncology compound afatinib,* including lung cancer-related symptoms and quality of life (QoL)...
Transplant, Lymphoma Patients At Greater Risk Of Melanoma
10/06/2012
Melanoma is on the rise nationally, and transplant recipients and lymphoma patients are far likelier than the average person to get that form of skin cancer and to die from it, a Mayo Clinic review has found. That is because their immune systems tend to be significantly depressed, making early detection of melanoma even more important, says co-author Jerry Brewer, M.D., a Mayo dermatologist...
Boehringer Ingelheim has announced new patient-reported health-related outcomes for its investigational oncology compound afatinib,* including lung cancer-related symptoms and quality of life (QoL)...
HIV Helps Explain Rise Of Anal Cancer In US Males
10/05/2012
The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute. Anal cancer in the U.S. is rare, with an estimated 6,230 cases in 2012, but incidence has been steadily increasing in the general population since 1940...
HIV Helps Explain Rise Of Anal Cancer In US Males
10/05/2012
The increase in anal cancer incidence in the U.S. between 1980 and 2005 was greatly influenced by HIV infections in males, but not females, according to a study published October 5 in the Journal of the National Cancer Institute. Anal cancer in the U.S. is rare, with an estimated 6,230 cases in 2012, but incidence has been steadily increasing in the general population since 1940...
HIV Drug Shows Efficacy In Treating Mouse Models Of HER2+ Breast Cancer
10/05/2012
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute. Breast cancer is one of the most common causes of cancer deaths in the U.S. with approximately 39,520 women succumbing to the disease in 2011...
Rural Colon Cancer Patients Are More Likely To Receive Late-Stage Diagnosis And Inferior Treatment
10/05/2012
Colon cancer patients living in rural areas are less likely to receive an early diagnosis, chemotherapy, or thorough surgical treatment when compared with patients living in urban areas...